Full-Time

Junior Business Analyst

Japanese Speaking

STEM Healthcare

STEM Healthcare

501-1,000 employees

Data-driven advisory optimizing life-science commercialization

No salary listed

London, UK

Hybrid

Hybrid role; some on-site at Holborn Gate office in London.

Category
Business & Strategy (1)
Requirements
  • Full proficiency in English and Japanese is a must.
  • The ideal candidate must have a Science based degree in subjects with numerical emphasis (such as Chemistry, Physics, Mathematics, Engineering etc) or experience as an Analyst.
  • Strong communication and project management skills to handle multiple projects with different stakeholders.
  • Experience in using MS Excel and PowerPoint.
  • Be proactive, with drive and ambition and a strong work ethic to grow in a dynamic environment with good opportunities to help develop and further the business as a whole.
  • Analytical thinking.
  • Problem-solving.
Responsibilities
  • Liaising with internal STEM senior leadership and local project teams to establish project delivery requirements.
  • Client facing – relationship building through project set up and delivery as well as managing external requests and deadlines.
  • Managing multiple client projects.
  • Building and maintaining MS Excel databases from source data.
  • Analysing client data using quantitative and qualitative methods to evaluate key performance indicators.
  • Pressure testing source data and identifying areas for investigation.
  • Collaborating with Project leaders and local teams to interpret data and formulate action plans and recommendations for clients.
  • Produce high quality presentations and other deliverables for clients using MS PowerPoint.
  • Supporting members in the analysis team to meet client deadlines and drive development and efficiencies within the team.

STEM Healthcare provides advisory services to pharmaceutical and life science companies to improve commercial performance by measuring how well brand strategies are executed in the real world. The company uses a specific methodology and benchmarking data to analyze a product's progress at every stage, from early development to the end of its market life. Unlike competitors that may focus on isolated stages, STEM offers a connected approach through the Inizio Advisory network to simplify complex commercialization challenges. Its goal is to help clients increase their return on investment and ensure that important medicines successfully reach the patients who need them.

Company Size

501-1,000

Company Stage

Acquired

Total Funding

$110.9M

Headquarters

York, Pennsylvania

Founded

2007

Simplify Jobs

Simplify's Take

What believers are saying

  • Dermot Kenny leverages 25 years Novartis experience to drive STEM growth.
  • Leadership team includes CFO Josu Beristain, HR head Mairéad Kelly, China leader Veronica Zhao.
  • Inizio Advisory embedding provides connected intelligence for pharma client acceleration.

What critics are saying

  • Dermot Kenny delivers no growth or expansion after 4.5 years as CEO.
  • AI platforms like Veeva automate STEM's manual auditing within 12-24 months.
  • Inizio holding structure triggers cost-cutting and STEM rationalization in 18-36 months.

What makes STEM Healthcare unique

  • STEM quantifies strategic alignment from leadership to field execution in pharma.
  • STEM benchmarks commercial, medical, access, and manager team performance globally.
  • STEM integrates with Vynamic, Putnam, SmartAnalyst for comprehensive advisory services.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at STEM Healthcare who can refer or advise you

Benefits

Remote Work Options

Flexible Work Hours

Professional Development Budget

Company News

PharmaVoice
Dec 15th, 2021
STEM Marketing hires Dermot Kenny as CEO

All you have to do is check your mail and you will be directed back to PharmaVOICE.com Leading global pharmaceutical and life sciences auditing firm, STEM Healthcare, part of Ashfield Advisory, has appointed Dermot Kenny as its new CEO.